Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS
· Delayed Price · Currency is USD
8.56
+1.06 (14.13%)
At close: May 22, 2025
RAJAF Revenue
In the year 2024, Cordyceps Sunshine Biotech Holdings had annual revenue of $1.25M with 42.03% growth. Cordyceps Sunshine Biotech Holdings had revenue of $315.50K in the quarter ending December 31, 2023, with 210.58% growth.
Revenue
1.25M
Revenue Growth
+204.16%
P/S Ratio
758.83
Revenue / Employee
96.42K
Employees
15
Market Cap
951.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.25M | 370.95K | 42.03% |
| Dec 31, 2023 | 882.53K | 829.23K | 1,555.66% |
| Dec 31, 2022 | 53.30K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 202.08K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cuisine Solutions | 80.48M |
| Armanino Foods of Distinction | 69.40M |
| South Dakota Soybean Processors, LLC | 524.07M |
| ESG Inc. | 11.89M |
| Pyxus International | 2.48B |
| Crimson Wine Group | 71.52M |
| Vodka Brands | 47.84K |
| Global Pharmatech | 3.18M |